The Ochsner Medical Center PGY-2 Oncology Residency is an ASHP-acredited one-year program that provides the resident with advanced pharmacotherapy training in a diverse oncology patient population, including solid tumor, hematologic malignancies, bone marrow transplant, and cellular therapies. As an integral member of the multidisciplinary team, the resident will utilize evidence-based recommendations to optimize medication therapy and implement chemotherapy treatment regimens. Participation in patient care will occur in the acute and ambulatory settings, with daily opportunities for direct patient interaction, including education of patients and their caregivers.
Ochsner Health System is dedicated to excellence in patient care,education and research. This mission has been intricately entwinedthroughout all aspects of the Health System. Ochsner is one of thelargest non-university based physician training centers. The OchsnerHealth System pharmacy is a state-of-the-art facility with the latesttechnologies.
